STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts
STAT NewsTopic alignment 92
Missouri AG told Lilly to stop forcing hospitals to provide claims data to receive discounted medicines under 340B, a sign more states are pushing back against drugmakers.
Filed under
- 340Bmatch 92
Jeff Davis Examines Potential Legal Challenges to New 340B Medicare Payment Rule
Bass BerryTopic alignment 92
Medicare will cut billions from 340B, expand site-neutral payments in 2027
MedTech DiveTopic alignment 95
Also covered by BioPharma Dive, Healthcare Dive
CY 2027 OPPS Final Rule: What the 340B Changes Mean for Hospitals, Patients, and Pharma
Turquoise Health (blog and reports)Topic alignment 94
2027 Medicare OPPS final rule cuts 340B payments, expands site-neutral rates
HFMATopic alignment 95